Cisplatin is a chemotherapy medication used to treat a number of cancers. These include testicular cancer, ovarian cancer, cervical cancer, bladder cancer, head and neck cancer, esophageal cancer, lung cancer, mesothelioma, brain tumors and neuroblastoma. It is given by injection into a vein. Common side effects include bone marrow suppression, hearing problems, incl… WebCisplatin (PIM 132) Cisplatin 1. NAME 1.1 Substance 1.2 Group 1.3 Synonyms 1.4 Identification Numbers 1.4.1 CAS 1.4.2 Other Numbers 1.5 Brand Names, Trade Names …
Oxaliplatin - StatPearls - NCBI Bookshelf
WebFeb 17, 2024 · Cisplatin: Urine (13% to 17% within 1 hour); Platinum: Urine (35% to 51%) Half-Life Elimination. Children: Free drug: 1.3 hours; Total platinum: 44 hours. Adults: Cisplatin: 20 to 30 minutes; Platinum: ≥5 … WebDec 1, 1987 · Calculated pharmacokinetic parameters (peak concentrations, half-lives, areas under the curve) were compared with the corresponding values in patients at the maximal tolerated dose. Peak plasma concentrations were 2.4- to 20-fold higher in mice than in humans. Initial and terminal half-lives in mice were up to 6 times shorter than in … florists in winfield alabama
Long-term platinum excretion in patients treated with cisplatin
WebCisplatin side effects may be quite manageable. There are many options to help minimize or prevent the side effects of cisplatin. There is no relationship between the presence or severity of Cisplatin side effects and effectiveness of cisplatin. The following side effects are common (occurring in greater than 30%) for patients taking Cisplatin: WebMay 22, 2024 · Oxaliplatin is subject to rapid and extensive nonenzymatic biotransformation and is not metabolized by the CYP450 enzyme system. [23] Oxaliplatin half-life varies significantly depending on the resource consulted and the method used to determine half-life. [24] It is excreted in the urine (approximately 50%) and the feces (2%). WebCisplatin was administered to seven patients with advanced cancer in divided doses of 40 mg/m2 body surface daily for 5 consecutive days. The pharmacokinetics of total Pt was studied on the days 1, 3 and 5 of infusion. ... However, on day 5 of treatment patients showed increased alpha-half life and AUC of plasma Pt, as well as decreased Pt ... greece live score